发明授权
US08106069B2 Pyrrolo[2,3-b]pyridine derivatives active as kinase inhibitors and pharmaceutical compositions comprising them
有权
作为激酶抑制剂活性的吡咯并[2,3-b]吡啶衍生物和包含它们的药物组合物
- 专利标题: Pyrrolo[2,3-b]pyridine derivatives active as kinase inhibitors and pharmaceutical compositions comprising them
- 专利标题(中): 作为激酶抑制剂活性的吡咯并[2,3-b]吡啶衍生物和包含它们的药物组合物
-
申请号: US12766230申请日: 2010-04-23
-
公开(公告)号: US08106069B2公开(公告)日: 2012-01-31
- 发明人: Barbara Salom , Matteo D'Anello , Maria Gabriella Brasca , Patrizia Giordano , Katia Martina , Francesco Angelucci , Frederick Arthur Brookfield , William John Trigg , Edward Andrew Boyd , Jonathan Anthony Larard
- 申请人: Barbara Salom , Matteo D'Anello , Maria Gabriella Brasca , Patrizia Giordano , Katia Martina , Francesco Angelucci , Frederick Arthur Brookfield , William John Trigg , Edward Andrew Boyd , Jonathan Anthony Larard
- 申请人地址: IT Rome
- 专利权人: Pfizer Italia S.r.l.
- 当前专利权人: Pfizer Italia S.r.l.
- 当前专利权人地址: IT Rome
- 代理机构: Scully, Scott, Murphy & Presser, P.C.
- 主分类号: A61K31/44
- IPC分类号: A61K31/44 ; A61K31/50 ; A61K31/497 ; A61K31/445
摘要:
Compounds which are pyrrolo[2,3-b]pyridine derivatives or pharmaceutically acceptable salts thereof, their preparation process and pharmaceutical compositions comprising them are disclosed; these compounds are useful in the treatment of diseases caused by and/or associated with an altered protein kinase activity such as cancer, cell proliferative disorders, Alzheimer's disease, viral infections, auto-immune diseases and neurodegenerative disorders; also disclosed is a process under SPS conditions for preparing the compounds of the invention and chemical libraries comprising a plurality of them.
公开/授权文献
信息查询